Pdt Partners, LLC Rocket Pharmaceuticals, Inc. Transaction History

Pdt Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$12.37 - $18.41 $278,473 - $414,445	-22,512 Reduced 19.97%	90,217 $1.44 Million
Q2 2022 Aug 15, 2022	BUY	$7.96 - $16.64 $386,099 - $807,123	48,505 Added 75.52%	112,729 $1.55 Million
Q1 2022 May 16, 2022	BUY	$13.16 - $23.68 $845,187 - $1.52 Million	64,224 New	64,224 $1.02 Million

210

93.3M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $780M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.